摘要
Special Care in DentistryEarly View LETTER TO THE EDITOR Comment on: Incidence rate of osteonecrosis of jaw after cancer treated with bisphosphonates and denosumab: A systematic review and meta-analysis Efsun Somay, Corresponding Author Efsun Somay [email protected] orcid.org/0000-0001-8251-6913 Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, Ankara, Turkey Correspondence Efsun Somay, Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, 82. Street No: 26 Bahcelievler, Ankara, Turkey. Email: [email protected]Search for more papers by this author Efsun Somay, Corresponding Author Efsun Somay [email protected] orcid.org/0000-0001-8251-6913 Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, Ankara, Turkey Correspondence Efsun Somay, Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, 82. Street No: 26 Bahcelievler, Ankara, Turkey. Email: [email protected]Search for more papers by this author First published: 29 July 2023 https://doi.org/10.1111/scd.12909Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Zhang C, Shen G, Li H, et al. Incidence rate of osteonecrosis of jaw after cancer treated with bisphosphonates and denosumab: a systematic review and meta-analysis. Spec Care Dentist. 2023; 1-12.. doi:10.1111/scd.12877 2Vidal-Real C, Pérez-Sayáns M, Suárez-Peñaranda JM, Gándara Rey JM, García-García A. Osteonecrosis of the jaws in 194 patients who have undergone intravenous bisphosphonate therapy in Spain. Med Oral Patol Oral Cir Bucal. 2015; 20(3): e267-e272. 3Nicolatou-Galitis O, Papadopoulou E, Vardas E, et al. Alveolar bone histological necrosis observed prior to extractions in patients, who received bone-targeting agents. Oral Dis. 2020; 26(5): 955-966. 4Ruggiero SL, Dodson TB, Fantasia J, et al. American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw – 2014 update. J Oral Maxillofac Surg. 2014; 72: 1938-1956. 5Yamazaki T, Yamori M, Ishizaki T, et al. Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: a cohort study. Int J Oral Maxillofac Surg. 2012; 41: 1397-1403. Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation